Navigation Links
Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
Date:8/19/2008

ard-looking statements include statements about the Karolinska Institute's and the SMI's plans for a prime-boost HIV vaccine clinical trial, the potential effect of the company's Vaxfectin(R) adjuvant and Biojector(R) 2000 needle-free injection system on vaccine performance, and the design and potential benefits of HIV DNA vaccines generally. Risks and uncertainties include whether Vical, the Karolinska Institute the SMI or others will continue development of the HIV vaccine; whether the SMI will sponsor and the Karolinska Institute will complete preclinical testing and conduct a Phase 1 trial using a Vaxfectin(R)-formulated DNA prime-MVA boost vaccination regimen; whether such trial, if conducted, will use the Biojector(R) 2000 needle-free injection system to deliver the DNA priming vaccine; whether Vaxfectin(R) will optimize the DNA vaccine priming of immune responses against the specific HIV vaccine targets and increase the performance of, or eliminate the need for, the MVA vaccine boost; whether Vaxfectin(R)-formulated DNA priming vaccines will increase the breadth and magnitude of immune responses to the prime-boost regimen; whether the prime- boost vaccine regimen will be effective in protecting humans against HIV infection or disease; whether the HIV vaccine will achieve the safety and immunogenicity endpoints in the Phase 1 trial; whether Vical or its collaborative partners will seek or gain approval to market any product candidates; whether Vical or its collaborative partners will succeed in marketing any product candidates; and additional risks set forth in the company's filings with the Securities and Exchange Commission. These forward- looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements.

Contact: Alan R. Engbring

(858) 646-1127

Website:

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
2. New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorials Bluhm Cardiovascular Institute
3. Seattles Swedish Cancer Institute First in U.S. to Treat Cancer Patient with Elekta VMAT
4. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
5. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
6. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
7. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
8. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
9. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
10. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
11. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015  SillaJen, Inc., a private clinical-stage ... immunotherapy products for cancer, today announced an oral ... Meeting of the American Association for Cancer Research ... version of its lead product candidate, Pexa-Vec (JX-594) ... oncolytic immunotherapy designed to 1) rapidly de-bulk tumors ...
(Date:4/20/2015)... , April 20, 2015 The preclinical contract ... pharmacokinetic testing of drugs and safety testing of medical devices, ... present at this week,s workshop " Drug Transporters in ADME: ... Baltimore, MD . The title of Dr. Hidalgo,s talk ... of a session entitled "Transporter Tools of the Future." ...
(Date:4/20/2015)... 20, 2015   Gateway Rehab and ... Institute today expanded its Naloxone: Increasing Access, Saving ... $50,000 grant from the Staunton Farm Foundation ... The yearlong research project, which ... their family members upon completion of treatment and ...
Breaking Medicine Technology:SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3
(Date:4/21/2015)... Atlantic Information Services, Inc. (AIS) is ... Eligibles Database, a brand-new, continually updated online subscription ... more than 9 million Medicare-Medicaid dual eligibles in ... billion in annual health care spending. Developed by ... also creates the industry-leading AIS’s Directory of Health ...
(Date:4/21/2015)... York, NY (PRWEB) April 21, 2015 Now, ... their day with the company’s new diet breakfast ... breakfast omelets are shipped in dry ice and are delivered ... and cheese, vegetable or southwestern omelets that not only appeal ... track and reach their ideal weight with healthy, low carbohydrate ...
(Date:4/21/2015)... San Antonio, TX (PRWEB) April 21, 2015 ... reconstruction, PRMA is actively involved in various components ... basic science fields. , "Breast reconstruction ... outcomes following mastectomy. Despite recent advances, many ... order to provide patients with optimal results," says ...
(Date:4/21/2015)... VA (PRWEB) April 21, 2015 The Science ... as a special addition to its Lunch Break Science program. ... World of Quarks! – taking guests from the subatomic world ... form. , The Museum invites members of the community to ... the Jefferson Lab physicist. Guests will delve into the nucleus ...
(Date:4/21/2015)... Spring and summer are popular seasons to ... for the holidays or simply taking vacations. Deciding what ... can be a difficult choice. Pet-friendly accommodations are gaining ... becoming a more common option. Royal Flush Havanese ... pet-friendly accommodations a positive experience. , 1.) Firstly, it ...
Breaking Medicine News(10 mins):Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 2Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 3Health News:Diet Doc Makes Dieting for People on the Go Easier than ever before with Pre-Packaged Diet Meals, Desserts, Snacks and new Breakfast Omelets 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 2Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 3Health News:Royal Flush Havanese Announces 5 Tips for a Successful Stay in Pet-Friendly Accommodations 4
... hepatitis B-related liver damage should receive lifelong antiviral treatment ... study shows that they lack cellular immunity against the ... These findings are in the March issue of ... & Sons. The article is also available online at ...
... article appearing in the March 2009 issue of the ... may lead to improvements in the efficacy of the ... discovered a new role for type I interferon, in ... stimulate an immune response against the bacterium known to ...
... 26 A large new study provides evidence ... women from Parkinson,s disease. The study was released today and ... Annual Meeting in Seattle, April 25 to May 2, 2009.The ... lifespan (number of years from first menstruation to menopause) had ...
... decision issued by the U.S. District Court for the ... for the insurance industry. The February 13 ruling from ... the court entered two months earlier establishing that Texas ... policies to advance defense costs incurred in connection with ...
... and radiation used to save cancer patients, lives can ... new field called oncofertility has advanced the ability of ... and children who are diagnosed with cancer. Yet, many ... their patients. , A leading oncofertility researcher and a ...
... Most people accustomed to working within a managed care or ... care or the cost of that care. Often they ... they get the bill.But as healthcare costs skyrocket and layoffs ... (HDHP) with health savings accounts (HSA) are growing in popularity. ...
Cached Medicine News:Health News:Liver transplant recipients with hepatitis B may need lifelong antiviral treatment 2Health News:New discovery gives tuberculosis vaccine a shot in the arm 2Health News:Reproductive Factors May Protect Women from Parkinson's Disease 2Health News:Reproductive Factors May Protect Women from Parkinson's Disease 3Health News:Patton Boggs Wins Landmark Insurance Case for Client 2Health News:New tool guides doctors to save cancer patients' fertility 2Health News:New tool guides doctors to save cancer patients' fertility 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 2Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 3Health News:Five Steps to Improve Care and Lower the Cost of Your Surgery 4
... Implant System provides todays surgeon with ... head replacement. Modular stem and ... while minimizing ligamentous and soft tissue ... guide assists in both the radial ...
... modular radial head system employs the advantages ... to create the next generation of modular ... part, modular design, the implant system offers ... the patients anatomy. In addition, the capability ...
All Padgett bipolar forceps are foot activated. The standard-type connectors fit generators utilizing the standard receivers for small "banana" inserts. All Padgett bipolar foot activated forceps an...
For connection to the bipolar output of electrosurgical generators....
Medicine Products: